-
公开(公告)号:EP2827841B1
公开(公告)日:2024-09-18
申请号:EP13764971.1
申请日:2013-03-15
IPC分类号: A61K9/08 , A61K38/00 , A61K47/30 , A61K38/16 , A61P31/00 , A61P31/02 , A61P31/04 , A61P41/00 , A01N37/46
CPC分类号: A61K9/06 , A61L15/42 , A61L15/46 , A61L24/001 , A61L24/0015 , A61L24/0036 , A61L2400/0420130101 , A01N37/46 , A01N37/44 , A61K31/715 , A61K31/765 , A61K38/02 , A61K38/16 , A61P13/02 , A61P17/00 , A61P17/02 , A61P31/00 , A61P31/02 , A61P31/04 , A61P41/00 , A61P5/46 , A61P7/02 , A61P7/04 , A61P3/10 , Y02A50/30
-
公开(公告)号:EP3658625B1
公开(公告)日:2024-06-12
申请号:EP18838499.4
申请日:2018-07-27
-
3.
公开(公告)号:EP4272823A3
公开(公告)日:2024-01-10
申请号:EP23188505.4
申请日:2016-05-27
发明人: JUN, Hee Sook , PARK, Eun Young , HONG, Yeon Hee
摘要: Provided are a pharmaceutical composition for preventing or treating muscle atrophy or sarcopenia including glucagon-like peptide-1 (GLP-1), a GLP-1 fragment, a GLP-1 secretion enhancer, a GLP-1 degradation inhibitor, a GLP-1 receptor (GLP-1R) agonist, or exendin-4, and a method of treating muscle atrophy or sarcopenia by using the pharmaceutical composition. When the pharmaceutical composition for preventing or treating muscle atrophy or sarcopenia provided in the present invention is administered to a subject having sarcopenia or muscle atrophy, reduced body weight, skeletal muscle mass, and grip strength, which are caused by sarcopenia or muscle atrophy, and expression levels of genes involved in muscle production may be restored to normal states, and therefore, the composition may be widely applied to the development of effective therapeutic agents for sarcopenia or muscle atrophy.
-
公开(公告)号:EP4234015A3
公开(公告)日:2023-11-22
申请号:EP23162149.1
申请日:2014-03-17
申请人: Tolmar, Inc.
IPC分类号: A61K31/568 , A61K9/48 , A61K47/30 , A61P5/26
摘要: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed toprovide optimum serum testosterone levels over an extended period.
-
公开(公告)号:EP2704750B1
公开(公告)日:2023-11-01
申请号:EP12777664.9
申请日:2012-04-27
IPC分类号: A61K47/30 , A61K9/127 , A61K39/38 , A61K31/445
-
公开(公告)号:EP4181962A1
公开(公告)日:2023-05-24
申请号:EP21842780.5
申请日:2021-07-07
申请人: The Regents of University of California , Mayo Foundation for Medical Education and Research , Boston Scientific Scimed, Inc.
IPC分类号: A61K47/30 , A61K47/42 , C07K14/435 , C07K14/78
-
公开(公告)号:EP4126822A1
公开(公告)日:2023-02-08
申请号:EP21774577.7
申请日:2021-03-24
IPC分类号: C07D231/06 , A61K31/415 , A61K47/30 , A61K9/10
-
公开(公告)号:EP4084830A1
公开(公告)日:2022-11-09
申请号:EP21736205.2
申请日:2021-01-04
发明人: XU, Ting , DEL RE, Christopher , KWON, Junpyo
-
公开(公告)号:EP4081191A1
公开(公告)日:2022-11-02
申请号:EP20851221.0
申请日:2020-12-22
申请人: Centre National de la Recherche Scientifique (CNRS) , Université Paul Sabatier Toulouse III , Institut National de la Santé et de la Recherche Médicale (INSERM)
发明人: BLANZAT, Muriel , JEBBAWI, Ranime , POUPOT, Rémy , TURRIN, Cédric-Olivier , SIMON, Michel , CLEMENT, Emily , LABIE, Hélène , OUKHRIB, Abdelouahd
IPC分类号: A61K9/127 , A61K31/675 , A61K31/80 , A61K47/30 , A61P17/06
-
公开(公告)号:EP3043824B1
公开(公告)日:2022-07-06
申请号:EP14843357.6
申请日:2014-09-12
-
-
-
-
-
-
-
-
-